The stomach story only takes BPC-157 so far
Its connection to stomach juice is memorable. That still leaves the under-the-tongue question open.
Where the name comes from
BPC-157 is made in a lab. It's based on part of a protein reported in human stomach juice, rather than being a natural hormone your body makes.
I can see why the stomach connection sticks. It sounds like a clue that swallowing it might work. But where an idea came from doesn't tell us how a medicine travels through a person.
There are three separate questions here: can it survive, can it reach the blood, and can it help? The BPC-157 research review describes a lot of animal work and very little human evidence. That gap matters more than the reassuring name.
What the rat experiment found
In a stomach-ulcer study in rats, researchers compared delivery into muscle with delivery into the stomach. Ulcer healing improved, with the muscle route doing better.
That's a real finding about those rats. It doesn't tell us how much BPC-157 reaches a person's blood from under the tongue. It also doesn't establish a treatment for people with stomach problems or injuries.
The route comparison is useful because it shows why the details count. Change the species, the preparation or the route, and there's a new question to answer. The old result doesn't automatically come along.
Two people cannot settle safety
A small intravenous safety report followed two adults receiving BPC-157 into a vein; both had received it this way before. It reported no adverse events and no measurable changes in the safety blood tests it checked.
There was no comparison group. A report with two people can't settle rare harms or long-term safety. It wasn't a test of whether BPC-157 heals an injury, either.
Giving something into a vein also skips the crossing we're asking about. These observations don't tell us what happens with a preparation under the tongue. An encouraging early report can still leave the main question unanswered.
The cautions are part of the story
BPC-157 isn't FDA-approved. FDA's page current as of April 22, 2026 lists it as nominated but withdrawn. That means the request was withdrawn, not that FDA cleared it for compounding. The listing doesn't tell us when its nomination was withdrawn.
FDA still lists concerns about immune reactions and impurities. Long-term safety in people remains unknown. A familiar origin doesn't make those concerns smaller.
The questions page helps separate what has been measured from what is still being assumed.